Press releases
- Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
- Evolent Announces First Quarter 2024 Results
- Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
- Evolent Announces Fourth Quarter and Full Year 2023 Results
- Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
More ▼
Key statistics
As of last trade, Evolent Health Inc (9EH:FRA) traded at 26.20, 16.96% above the 52 week low of 22.40 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.20 |
---|---|
High | 26.20 |
Low | 26.20 |
Bid | 26.40 |
Offer | 26.60 |
Previous close | 25.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 116.20m |
Free float | 111.59m |
P/E (TTM) | -- |
Market cap | 3.13bn USD |
EPS (TTM) | -1.25 USD |
Data delayed at least 15 minutes, as of May 10 2024 07:05 BST.
More ▼